High Level political forum:
Pharmaceutical Price Shifts
This committee examines how global pricing, patent protections, and pharmaceutical monopolies affect access to essential medicines. Delegates will explore how to preserve incentives for medical innovation while preventing anticompetitive practices and ensuring that vulnerable populations can obtain affordable treatment. The committee will seek cooperative policies that strengthen medicine access during humanitarian crises and advance global public-health and sustainable-development goals.
Background Guide
Background Guides are Available!
-
![]()
Colin Horwath
Chair
-
![]()
Liam Kenney
Co-Chair
-
Pharmaceutical patent regulation is about balancing the rights of drug companies with the need for people to have access to affordable medicines. International rules allow companies to protect their inventions while also giving governments options to make medicines more available when public health is at risk.
-
Millions of people around the world cannot get the medicines they need because of high prices, limited resources, and problems with how medicines are produced and distributed. This topic focuses on how governments, drug companies, and organizations can work together to make medicines more affordable and available while still encouraging the development of new treatments.